Phase 1 Pharmacokinetics, Safety, and Tolerability Study
Clinical trial NCT04067947 · COMPLETED
Trial details
- NCT number
- NCT04067947
- Sponsor
- Xgene Pharmaceutical Group
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-08
- Primary completion
- 2019-12-03
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.